Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches

[1]  O. A. Hidalgo,et al.  Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor. , 2016, Medicinal chemistry (Shariqah (United Arab Emirates)).

[2]  L. Garcia-Segura,et al.  Microglial dependent protective effects of neuroactive steroids. , 2016, CNS & neurological disorders drug targets.

[3]  Janneth González,et al.  Systems biology study of mucopolysaccharidosis using a human metabolic reconstruction network. , 2016, Molecular genetics and metabolism.

[4]  V. Echeverria,et al.  Nicotine-Derived Compounds as Therapeutic Tools Against Post-Traumatic Stress Disorder. , 2015, Current pharmaceutical design.

[5]  G. Ashraf,et al.  Mechanisms of PDGFRalpha promiscuity and PDGFRbeta specificity in association with PDGFB. , 2015, Frontiers in bioscience.

[6]  A. Nimmerjahn,et al.  Large-scale recording of astrocyte activity , 2015, Current Opinion in Neurobiology.

[7]  Jie Wu,et al.  Activation of α7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: Implications for Parkinson's disease , 2015, Neuropharmacology.

[8]  Christer Halldin,et al.  Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients. , 2015, The Journal of clinical investigation.

[9]  D. Coulter,et al.  Role of astrocytes in epilepsy. , 2015, Cold Spring Harbor perspectives in medicine.

[10]  G. Barreto,et al.  Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease , 2015, Front. Aging Neurosci..

[11]  F. Benfenati,et al.  Direct Conversion of Fibroblasts into Functional Astrocytes by Defined Transcription Factors , 2014, Stem cell reports.

[12]  Luis M. Garcia-Segura,et al.  The neuroprotective actions of oestradiol and oestrogen receptors , 2014, Nature Reviews Neuroscience.

[13]  G. Aliev,et al.  Computational Analysis and Functional Prediction of Ubiquitin Hypothetical Protein: A Possible Target in Parkinson Disease. , 2015, Central nervous system agents in medicinal chemistry.

[14]  G. Barreto,et al.  PDGF-BB Protects Mitochondria from Rotenone in T98G Cells , 2015, Neurotoxicity Research.

[15]  L. Garcia-Segura,et al.  Tibolone protects T98G cells from glucose deprivation , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  Nathan Intrator,et al.  Systems biology and brain activity in neuronal pathways by smart device and advanced signal processing , 2014, Front. Genet..

[17]  G. Barreto,et al.  Protection after stroke: cellular effectors of neurovascular unit integrity , 2014, Front. Cell. Neurosci..

[18]  I. Samudio,et al.  Paracrine factors of human mesenchymal stem cells increase wound closure and reduce reactive oxygen species production in a traumatic brain injury in vitro model , 2014, Human & experimental toxicology.

[19]  L. Garcia-Segura,et al.  Selective estrogen receptor modulators regulate reactive microglia after penetrating brain injury , 2014, Front. Aging Neurosci..

[20]  L. Garcia-Segura,et al.  Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease , 2014, Front. Cell. Neurosci..

[21]  K. Ülgen,et al.  Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network , 2014, FEBS open bio.

[22]  Anastasia G. Efthymiou,et al.  Comparison of the Gene Expression Profiles of Human Fetal Cortical Astrocytes with Pluripotent Stem Cell Derived Neural Stem Cells Identifies Human Astrocyte Markers and Signaling Pathways and Transcription Factors Active in Human Astrocytes , 2014, PloS one.

[23]  J. Rossignol,et al.  Transplants of Adult Mesenchymal and Neural Stem Cells Provide Neuroprotection and Behavioral Sparing in a Transgenic Rat Model of Huntington's Disease , 2014, Stem cells.

[24]  M. Noble,et al.  Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons , 2014, EMBO molecular medicine.

[25]  F. Schnorrer,et al.  Ret rescues mitochondrial morphology and muscle degeneration of Drosophila Pink1 mutants , 2014, The EMBO journal.

[26]  Dohyun Han,et al.  Characterization of the membrane proteome and N-glycoproteome in BV-2 mouse microglia by liquid chromatography-tandem mass spectrometry , 2014, BMC Genomics.

[27]  L. Pellerin,et al.  Unraveling the complex metabolic nature of astrocytes , 2013, Front. Cell. Neurosci..

[28]  A. Araque,et al.  Astrocyte-neuron interaction at tripartite synapses. , 2013, Current drug targets.

[29]  H. Kitano,et al.  Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map , 2013, Molecular Neurobiology.

[30]  M. Sasahara,et al.  The Roles of PDGF in Development and During Neurogenesis in the Normal and Diseased Nervous System , 2013, Journal of Neuroimmune Pharmacology.

[31]  N. Patel,et al.  GDNF, NGF and BDNF as therapeutic options for neurodegeneration. , 2013, Pharmacology & therapeutics.

[32]  Ronan M. T. Fleming,et al.  A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.

[33]  H. Ulrich,et al.  Functions of neurotrophins and growth factors in neurogenesis and brain repair , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[34]  C. Pouton.  Stem Cell Technology , 2013 .

[35]  C. Palm,et al.  Effects of heat shock protein 72 (Hsp72) on evolution of astrocyte activation following stroke in the mouse , 2012, Experimental Neurology.

[36]  G. Barreto,et al.  Mitochondrial functions in astrocytes: Neuroprotective implications from oxidative damage by rotenone , 2012, Neuroscience Research.

[37]  Kevin Ellsworth,et al.  α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation , 2012, Journal of Neuroinflammation.

[38]  Z. Katušić,et al.  Brain-derived neurotrophic factor increases expression of MnSOD in human circulating angiogenic cells. , 2012, Microvascular research.

[39]  C. Shatz,et al.  Neuroprotection from Stroke in the Absence of MHCI or PirB , 2012, Neuron.

[40]  R. Giffard,et al.  Astrocyte Proliferation Following Stroke in the Mouse Depends on Distance from the Infarct , 2011, PloS one.

[41]  Mohammad Zaefizadeh,et al.  Optimized Quantities of GDNF Overexpressed by Engineered Astrocytes Are Critical for Protection of Neuroblastoma Cells Against 6-OHDA Toxicity , 2011, Journal of Molecular Neuroscience.

[42]  George E. Barreto,et al.  Astrocytic-neuronal crosstalk: Implications for neuroprotection from brain injury , 2011, Neuroscience Research.

[43]  J. Hur,et al.  Stem cell technology for neurodegenerative diseases , 2011, Annals of neurology.

[44]  R. Giffard,et al.  Increased Brain Injury and Worsened Neurological Outcome in Interleukin-4 Knockout Mice After Transient Focal Cerebral Ischemia , 2011, Stroke.

[45]  Vladimir Parpura,et al.  Ca(2+) sources for the exocytotic release of glutamate from astrocytes. , 2011, Biochimica et biophysica acta.

[46]  F. Benvenuto,et al.  Neuroprotective features of mesenchymal stem cells. , 2011, Best practice & research. Clinical haematology.

[47]  J. Hébert,et al.  Signaling Pathways in Reactive Astrocytes, a Genetic Perspective , 2011, Molecular Neurobiology.

[48]  M. Sofroniew,et al.  Reactive astrocytes as therapeutic targets for CNS disorders , 2010, Neurotherapeutics.

[49]  M. Nedergaard,et al.  Functions of astrocytes and their potential as therapeutic targets , 2010, Neurotherapeutics.

[50]  A. Anghelescu,et al.  Traumatic brain injury : Current endeavours and trends for neuroprotection and related recovery , 2011 .

[51]  Malcolm J. McConville,et al.  Systems Biology: The Next Frontier for Bioinformatics , 2011, Adv. Bioinformatics.

[52]  O. Bizzozero,et al.  Accumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis , 2010, Journal of neuroscience research.

[53]  H. Mochizuki,et al.  Use of growth factors for the treatment of Parkinson’s disease , 2010, Expert review of neurotherapeutics.

[54]  R. Mailman,et al.  Smoking duration, intensity, and risk of Parkinson disease , 2010, Neurology.

[55]  A. Schneider,et al.  Neurotrophic Growth Factors for the Treatment of Amyotrophic Lateral Sclerosis: Where Do We Stand? , 2010, Front. Neurosci..

[56]  A. Caplan,et al.  The potential of mesenchymal stem cells for neural repair. , 2010, Discovery medicine.

[57]  Qing‐Li Zhao,et al.  Neuroprotective effects of PDGF against oxidative stress and the signaling pathway involved , 2009, Journal of neuroscience research.

[58]  S. Strittmatter,et al.  Rho-Associated Kinase II (ROCKII) Limits Axonal Growth after Trauma within the Adult Mouse Spinal Cord , 2009, The Journal of Neuroscience.

[59]  J. Kordower,et al.  Are growth factors the answer? , 2009, Parkinsonism & related disorders.

[60]  L. Garcia-Segura,et al.  Selective estrogen receptor modulators decrease reactive astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones. , 2009, Endocrinology.

[61]  Daniel H. Geschwind,et al.  Neuroscience in the era of functional genomics and systems biology , 2009, Nature.

[62]  G. Perea,et al.  Tripartite synapses: astrocytes process and control synaptic information , 2009, Trends in Neurosciences.

[63]  Gilles Clermont,et al.  Computational disease modeling – fact or fiction? , 2009, BMC Systems Biology.

[64]  Tian Wen-yan.  Effects of tibolone on apoptosis of neurons after cerebral ischemia-reperfusion injury in rats , 2009 .

[65]  M. Mattson,et al.  Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease , 2008, Annals of the New York Academy of Sciences.

[66]  A. Vercelli,et al.  Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis , 2008, Neurobiology of Disease.

[67]  E. Schutter.  Why Are Computational Neuroscience and Systems Biology So Separate? , 2008, PLoS Comput. Biol..

[68]  Johanna Andrae,et al.  Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.

[69]  J. Silver,et al.  CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure , 2008, Experimental Neurology.

[70]  Max R. Bennett,et al.  A Quantitative Model of ATP-Mediated Calcium Wave Propagation in Astrocyte Networks , 2008 .

[71]  K. Ülgen,et al.  Reconstruction and flux analysis of coupling between metabolic pathways of astrocytes and neurons: application to cerebral hypoxia , 2007, Theoretical Biology and Medical Modelling.

[72]  K. Marder,et al.  Pooled analysis of tobacco use and risk of Parkinson disease. , 2007, Archives of neurology.

[73]  D. Pogocki,et al.  Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders. , 2007, European journal of pharmacology.

[74]  L. Garcia-Segura,et al.  Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone , 2007, The European journal of neuroscience.

[75]  J. Rothstein,et al.  Mechanisms of Disease: astrocytes in neurodegenerative disease , 2006, Nature Clinical Practice Neurology.

[76]  Yen-Zhen Lu,et al.  Protection of ischemic brain cells is dependent on astrocyte-derived growth factors and their receptors , 2006, Experimental Neurology.

[77]  N. Åberg,et al.  Aspects of Growth Hormone and Insulin-Like Growth Factor-I Related to Neuroprotection, Regeneration, and Functional Plasticity in the Adult Brain , 2006, TheScientificWorldJournal.

[78]  R. Przewłocki,et al.  COMPARISON OF GENE EXPRESSION PROFILES , 2006 .

[79]  J. Daly,et al.  A revised structure for alkaloid 235C isolated from skin extracts of mantellid (Mantella) frogs of Madagascar. , 2005, Journal of natural products.

[80]  J. Daly,et al.  Alkaloids from amphibian skin: a tabulation of over eight-hundred compounds. , 2005, Journal of natural products.

[81]  Steven Song,et al.  The role of pericytes in blood-vessel formation and maintenance. , 2005, Neuro-oncology.

[82]  J. Meldolesi,et al.  Astrocytes, from brain glue to communication elements: the revolution continues , 2005, Nature Reviews Neuroscience.

[83]  K. Houkin,et al.  Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[84]  D. Yildiz.  Nicotine, its metabolism and an overview of its biological effects. , 2004, Toxicon : official journal of the International Society on Toxinology.

[85]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[86]  J. Chatton,et al.  Brain-Derived Neurotrophic Factor Stimulates Energy Metabolism in Developing Cortical Neurons , 2003, The Journal of Neuroscience.

[87]  R. Islamov,et al.  Raloxifene analog LY117018 enhances the regeneration of sciatic nerve in ovariectomized female mice , 2003, Brain Research.

[88]  D. Brooks,et al.  Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease , 2003, Nature Medicine.

[89]  H. Kim,et al.  Platelet-derived growth factor signaling and human cancer. , 2003, Journal of biochemistry and molecular biology.

[90]  L. Delbressine,et al.  The in vivo human metabolism of tibolone. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[91]  H. Bramlett,et al.  Neuropathological protection after traumatic brain injury in intact female rats versus males or ovariectomized females. , 2001, Journal of neurotrauma.

[92]  Tønder Je,et al.  Agonists at the a4b2 Nicotinic Acetylcholine Receptors Relationships and Molecular Modelling , 2001 .

[93]  P. Olesen,et al.  Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modelling. , 2001, Current medicinal chemistry.

[94]  R. Dringen,et al.  Metabolism and functions of glutathione in brain , 2000, Progress in Neurobiology.

[95]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[96]  M. Chopp,et al.  Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. , 1999, Spine.

[97]  W. Rostène,et al.  [Action of SERM and SAS (tibolone) on breast tissue]. , 1999, Contraception, fertilite, sexualite.

[98]  M. Drumm.  in vivo. , 1999 .

[99]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[100]  J. Krupiński,et al.  A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. , 1997, Stroke.

[101]  B. Chern-Hughes.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women , 1996 .

[102]  M. Mattson,et al.  PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[103]  G A Colditz,et al.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. , 1995, The New England journal of medicine.

[104]  G. Colditz,et al.  Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. , 1993, American journal of obstetrics and gynecology.

[105]  M. Jarvik.  Beneficial effects of nicotine. , 1991, British journal of addiction.